drugset / Trial / NCT02182388
Single Rising Oral Doses of BI 207127 NA as Powder in the Bottle in Healthy Male Subjects
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of this trial was to investigate the safety, tolerability, pharmacokinetics, and relative bioavailability of BI 207127 NA as powder in the bottle (PIB) and solid oral dosage form (tablets) without and with food.
Timeline
- Start
- 2007-01
- Primary completion
- 2007-05
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Deleobuvir | Small molecule | — | Oral |
Indications
No indication recorded.